AMA Resolution Supporting McCain/Schumer Is Referred For Further Study
An American Medical Association resolution in support of the recently introduced McCain/Schumer generic drug bill has been referred to the organization's Board of Trustees for further investigation.
You may also be interested in...
The revised McCain/Schumer generic drug bill eliminates the automatic stay of approval under current patent challenge procedures.
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011
FDA appears headed for a showdown with clinicians and the pharmaceutical industry over the proposed new clinical trial endpoints for acute bacterial skin and skin structure infections, the guidance's approach for justifying a non-inferiority margin and proposed changes in the types of patients that should be enrolled in trials